INTRODUCTION
Despite recent advances in the treatment of metastatic and local recurrent renal cell carcinoma (RCC), tumour spread is still highly resistant to any therapy. RCC remains a disease for which only complete surgical excision of the tumour can assure long-term survival. In 1963 Robson demonstrated that radical nephrectomy was associated with an increased survival rate compared with simple nephrectomy (1). Radical nephrectomy has been accepted as the standard treatment for patients with potentially curable localized disease (1, 2). However, the management of the increased number of patients with small RCCs limited to the kidney and with a normal contralateral kidney has been the subject for discussion during the last years.
Nephron-sparing surgery has become a successful procedure when there is a need of preservation of functioning renal parenchyma (Table 1 ). The need is present when renal function is of relevant clinical concern, as in patients with a solitary kidney or bilateral tumours and in patients with compromised renal function, which could be markedly decreased if the entire kidney was to be removed. Examples are patients at risk for future renal impairment from intercurrent disorders such as diabetic nephropathy, chronic pyelonephritis, renovascular hypertension, kidney stone or cystic disease (3). In addition, conservative surgery is indicated for various benign lesions such as oncocytoma, angiomyolipoma, and complicated cysts. During the last decade there has been a trend towards nephron-sparing surgery also in localized small tumours with a normal functioning contralateral kidney (4). It has become widely accepted that partial nephrectomy is a commonly used technique in the treatment of properly selected patients (Table 1) .
CLINICAL STAGING
As a consequence of the diagnostic advances and the increased use of transabdominal ultrasound and computerized tomography, a great number of asymptomatic renal tumours have been detected (5). These incidentally detected tumours tend to be smaller, of lower stage and with better overall survival than symptomatic RCC (6). These tumours seem to be optimal for partial nephrectomy. However, during the radiological work-up of RCCs, renal vein involvement might be invisible in a high number of tumours. Also microscopic perirenal growth and lymph node metastases remain difficult to detect by any radiological investigation despite of continuous radiological improvements. Using radical nephrectomy, such local tumour invasion will be removed as a consequence of the surgical technique but might be undetected using partial nephrectomy. Also small thrombus formations in the renal vein can be undiscovered during nephron-sparing surgery. Thus a number of patients operated with nephronsparing surgery might be at risk to be understaged except possibly in highly experienced centres. Taking into account that surgery remains the only curative therapy, a number of patients with limited local spread or lymph node metastases might be cured with radical nephrectomy and extirpation of affected lymph nodes (7). Therefore, adequate preoperative evaluation and careful visual inspection are critical for partial nephrectomy.
IS SMALL RENAL CELL CARCINOMA LESS MALIGNANT?
In a recent study from our department, tumour progression was not demonstrated in patients with pT1 N0M0 RCCs less than 3 cm in diameter (8). However, small tumours can be of any stage and Eschwege et al. (9) reported 12 patients with stage pT3 lesions out of 91 patients with tumours having a maximal diameter of 3 cm. Furthermore, reviewing the relation between tumour size and tumour stage in our material we found that 6 out of 40 tumours smaller than 5 cm had local tumour invasion. Our result was confirmed by Polascik et al. (10) who found that 5 of 27 tumours smaller than 3.5 cm (18 %) had penetrated the renal capsule. In a previous study on stage I tumours we found that 3 of 7 tumours smaller than 3 cm were aneuploid and aneuploid tumours usually have a higher incidence of local tumour invasion in the surrounding normal kidney tissue compared with diploid tumours (11) .
RATIONALE FOR NEPHRON-SPARING SURGERY VERSUS RADICAL NEPHRECTOMY
The potential benefit of preserving total renal function is the rationale for nephron-sparing surgery in patients with a normal contralateral kidney (4). The fact that RCCs are bilateral in 2-4 % of the cases is one reason for justified consideration of nephronsparing surgery in such patients. Approximately one half of the bilateral tumours is synchronous and the risk of later occurrence of RCC in the originally normal contralateral kidney is 1-2 % (12) . This consid-eration is most obvious in younger patients and those with hereditary history. But a high number of nephron-sparing operations would be needed in order to lower the risk for a rare patient from an impaired renal function because of a later metachronous tumour on the contralateral side. However, most patients with a secondary tumour in the contralateral kidney can be operated on with nephron-sparing surgery at that time. The prognosis for such patients is based on the concomitant metastatic spread and not on the primary surgical technique used (13, 14) .
Another reason for preserving renal parenchyma is the decreased risk of renal insufficiency after nephron-sparing surgery (15) . The removal of large amounts of normal renal parenchyma can result in progressive glomerulosclerosis in the renal remnant in rats. But other studies have suggested that rather than being maladaptive, hyperfiltration appropriately compensates for the loss of functional renal mass as after kidney donation or due to a unilateral malignancy (16) . In the Umeå study on renal function after radical nephrectomy only slight elevations in serum creatinine above the normal reference level were found in patients with normal preoperative values. During a 10-year follow-up period, there was normally no tendency of further decrease in renal insufficiency (8). The results showed that the elevated serum creatinine values after nephrectomy correlated to the serum creatinine values before surgery. These data obtained after radical nephrectomy were in line with the findings of Wishnow et al (17) . Furthermore, the follow-up creatinine values were lower or equivalent with the mean values reported in patients after nephron-sparing surgery (10, 13, 14) . In contrast, other studies comparing radical and partial nephrectomy, have demonstrated a significantly reduced risk of chronic renal insufficiency using nephron-sparing surgery (15, 18, 19) .
DISADVANTAGES OF NEPHRON-SPARING SURGERY
One of the major drawbacks of nephron-sparing surgery is the risk of a local tumor recurrence in the op- 
Elective indications
Indicental renal tumour (3-5 cm) with a normal functioning contralateral kidney erated kidney. The local recurrence rate for renal cell carcinomas smaller than 3 or up to 4 cm in diameter has been reported to be low in nephron-sparing surgery, but recurrence rates from 4-6 % in most series and up to 16 % have been reported (12, 13, 14, 20) . The explanations can be local recurrence due to incomplete surgical excision of the original tumour, tumour spillage, multifocal existing tumours or growth of a new tumour. The multifocal problem arises from the possibility of multicentric tumours described to occur in 7-25 % of RCC (21, 22) . In the study of Whang et al (22), 10 of 11 multifocal tumours occurred in kidneys with tumours smaller than 5 cm. After radical nephrectomy for localized renal cell carcinoma local recurrences are uncommon (8, 14, 23). However, the outcomes for small RCCs are comparable after both radical and partial nephrectomy. Lau et al (19) found no outcome difference in a retrospective study in overall survival, metastatic-free survival and local recurrence-free survival up to 15 years follow-up, analyzing 328 patients with a mean tumour size of 3.7 cm and 3.3 cm respectively. Similar data with no survival difference was reported in patients with pT1 tumors (< 7 cm) (24) .
SURGICAL MORBIDITY
During the last years refinements of the surgical technique in some centres have made this surgical procedure safer with acceptable complication rates (10) . Nephron-sparing surgery might give excellent results in good hands, but the patients have a risk of drawbacks from a more hazardous surgical procedure, e.g. a higher incidence of surgical morbidity including leakage of urine, postoperative bleeding, and acquired obstruction of the pelviureteric junction. Refinements of the preoperative selection of the patients and technical improvements have reduced the number of disadvantages. The surgical technique is safer and more effective using early vascular control, closure of the collecting system to prevent fistula formation and surface cooling (25, 26) . The frequency of local tumour recurrences after nephron-sparing surgery has been shown to be minimized by the use of frozen sections of the margins and by thorough examination for multiple lesions in the remnant kidney using intraoperative ultrasonography (25, 26) . The advances of the nephron-sparing techniques also are of utmost importance for the surgical treatment of patients with mandatory indications. The radical technique generally has lower morbidity rates compared with the frequencies reported after nephronsparing surgery which technically is more demanding (10, 27, 28) . Radical nephrectomy is probably the safest surgical alternative with a minimal risk of tumour recurrence and lowest cancer mortality (1, 21, 23, 28) . In two studies comparing radical with nephron-sparing surgery Butler et al (29) recorded 14 % and 15 % of perioperative complications respectively, while Lerner et al (27) recorded 2%and 4%surgical complications respectively, but none of these studies were randomized.
PARTIAL NEPHRECTOMY -SURGICAL STRATEGY
The indications for partial nephrectomy have changed from surgery in cases in which nephronsparing surgery must be performed to also those where radical nephrectomy can be performed. One critical point with nephron-sparing surgery is the cancer control, why especially enucleation, but also partial nephrectomy might be unfavourable when there is local tumour invasion. Preoperative planning is mandatory to find out the surgical technique of resection with a rim of healthy parenchyma or polar segmental nephrectomy. The technique for partial nephrectomy means that the kidney is mobilized within the Gerotas fascia but leaves the perirenal fat around the tumour intact (30) . Intraoperative ultrasound is advisable to assess the intraparenchymal depth and the limit of the tumour, the presence of collecting system and large vessels within the planned resection area. It can also be useful to identify additional multifocal tumours in the kidney. The renal vessels are identified and in cases with a complicated or time-consuming resection, temporary clamping of the vessels is indicated. Cooling of the kidney with ice-slush for 4-5 minutes, and intravenous mannitol administration before and after arterial clamping lower the risk of postoperative renal failure. Thereafter the renal capsule is incised around the tumour as planned and a dissection to remove the tumour with a margin of the normal parenchyma is done. At least couple of millimetres are needed for safe resection margins. Most small vessels can be identified before division, bleeding sites and large vessels can be directly controlled with suture ligatures. Also the collecting system structures can be repaired under direct vision. To visualize the defects in the collecting system and to minimize the risk for urine leakage it is advisable to use intrapelvic retrograde instillation of methylene blue. That strategy can aid to identify small injuries that might be unrecognized. The visual inspection of the section margin during the resection is critical for cancer control, and routine intraoperative frozen sections are recommended. Before closure of the parenchymal defect the use of fibrin sealants and hemostatic tissue bioadhesives reduce bleeding and urine leakage (31, 32) . When the parenchymal defect can not primarily be closed, perirenal fat or prepared bolsters of Surgicel are placed in the defect before the renal sutures. All these techniques reduce postoperative morbidity and make it possible that partial nephrectomy can safely be performed.
LAPAROSCOPIC NEPHRON-SPARING SURGERY
During the last decade laparoscopic surgery of RCC has become an established procedure. The laparoscopic partial nephrectomy was considered as a technically difficult procedure but its possibility has been proven in several publications (33, 34) . The reduction in morbidity and the length of recuperation after surgery encourage the use of this minimally invasive technique. Initially laparoscopic partial nephrectomy was started with superficially located peripheral small exophytic tumours. After the initial experience more complicated tumours have been treated. Today a large number of laparoscopic partial nephrectomies has been presented in the literature (33, 35, 36) . The contraindications for laparoscopic partial nephrectomy might include renal vein thrombus, multifocal tumours and locally advanced disease. Furthermore, prior renal surgery might complex the surgery. Generally the technique is a duplication of the established open surgical principles. In laparoscopy the use of fibrin sealants has facilitated the repair of collecting system (31) . The haemostasis has been simplified by the used hemostatic tissue bioadhesives (32) . The use of prepared absorbable bolsters in the parenchymal defect facilitates renorraphy, and this evolution has been useful also in open surgery. Nephron-sparing laparoscopic surgery is feasible as proven in several publications. The experience of this procedure exceeds today more than 300 published cases. Although laparoscopic nephron-sparing surgery is not yet validated, its use will increase in the management of small RCCs. However, its advantage in morbidity and oncological control, compared with the open surgery, has to be evaluated in randomised large multicentre prospective studies.
OTHER MINIMALLY INVASIVE NEPHRON-SPARING TECHNIQUES
Various other minimally invasive techniques include renal cryotherapy, radiofrequency ablation and extracorporeal high-intensity focused ultrasound.
RENAL CRYOTHERAPY
The goal with this technique is to achieve a targeted destruction of the tumour and surrounding tissue that would have otherwise been excised during partial nephrectomy. Thus this procedure should treat the tumour and the surrounding margin of normal healthy parenchyma. The cryotherapy technique works with specific cryophobes using liquid argon or nitrogen producing rapidly frozen tissue (an ice ball), achieving cell kill (37, 38) . Repeated freeze thaw cycles produce necrosis. Follow-up data are limited, but careful long-term radiological follow-up is needed and repeated procedures can be performed. This method can be performed using laparoscopic or percutaneous access.
HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
This technique uses ultrasound generated by piezoelectric element focused on the renal lesion similar to extracorporeal shock wave lithotripsy. The ablative destructions are related to the time, delivered energy, the targeted tissue and the surface area of the electrode. Only a few patients are currently reported in the literature yet, but this experimental method might become an effective technique (39, 40) . Incomplete tumour destruction limits its current use.
RADIOFREQUENCY TREATMENT
The radiofrequency ablation technique creates tissue destruction by molecular friction that increases temperatures up to 70º C (41) . This technique can also be performed using infusion of hypertonic saline resulting in a more rapid creation of larger lesions. This technique has been performed using CT or ultrasound guidance. More than 100 procedures are reported in the literature. A high frequency of residual tumours was reported in these patients but repeated treatments are possible. Also this technique is so far experimental. In a study of Randon et al 10 patients (11 tumours) were treated with radiofrequency followed by immediate or delayed nephrectomy. In this study there was residual visible tumour tissue in seven of the 11 treated tumours (42) . Other studies have found similar results with incomplete tumour destruction (43) .
These new minimally invasive nephron-sparing techniques will have an increased clinical relevance and application in the treatment of RCC. Laparoscopic nephron-sparing surgery will be possibly accepted as a standard treatment. The other techniques using probe ablation and non-invasion treatment as HIFU will be used in experimental settings and seem to have a considerable potential for the future. The technical advances and evaluation in this field will continue and will have an important potential for the treatment of patients with small RCCs. Today, open nephron-sparing surgical technique remains the standard treatment option and all other minimally invasive therapies should be compared with the results of that technique.
Another approach to the treatment of small incidental renal cell carcinoma in the elderly patients with high surgical risks is watchful waiting that can be a reasonable option for selected patients (44) .
SURVIVAL AND FOLLOW-UP AFTER SURGERY OF SMALL RCC
In our follow-up study at Umeå University Hospital the 5-year cancer specific survival rate was 95 % after radical nephrectomy for unselected pT1N0M0 tumours (45) . For selected patients with pT1N0M0 RCCs less than 5 cm, the 5-year cancer specific survival rate was 100 %, illustrating the generally less malignant character of small low-stage tumours. For patients operated upon with nephron-sparing surgery the 5-year survival rates have been reported to be 80 % to 90 %, but even 100 % for patients with tumours less than 4 cm (4, 6, 13, 20, 27) (Table 2 ). In two non-randomized studies comparing radical with nephron-sparing surgery similar survival rates have been reported. Butler et al (29) reported 97 and 100 % cancer-specific 5-year survival rates for the two groups respectively, although there were more than 11 % of T3 tumours in both treatment groups. Lerner et al (27) reported 97 % and 91 % 5-year-and 97 % and 84 % 10-year cancer specific survival rates respectively for patients with RCCs less than 4 cm. The follow-up data reported in our study indicate that the follow-up should be stage-dependent (46) . There was a significant stage-dependent risk for occurrence of metastases, in accordance with the results also reported by Hafez et al (47) . Based on our data there was no need for surveillance after a radical nephrectomy in patients with tumours confined to the kidney less than 5 cm in diameter. In another follow-up study after radical nephrectomy, Sandock et al (48) proposed similar follow-up recommendations for patients with tumours smaller than 2.5 cm. For patients operated upon with nephron-sparing surgery Hafez et al (47) found that patients operated upon with nephron-sparing surgery generally have a higher risk of local tumor recurrence. For these patients a more intense and regular radiological checkup including abdominal computerized tomograpy is necessary and results in higher health care costs than for patients treated with radical nephrectomy.
CONCLUSIONS
Bearing in mind the refractory nature of renal cell carcinoma to most therapeutic interventions besides surgery, the goal of therapy must be to prevent the localized tumors from becoming recurrent or metastatic. Although most small renal cell carcinomas seem to be suitable for nephron-sparing surgery, the risk of morbidity and residual tumor is not ignorable.
For selected patients with outstanding prognosis, as incidentally detected small renal cell carcinomas, nephron-sparing surgery is a good surgical alternative. Since the results have been excellent, it has been recommended for patients with tumour diametres smaller than 3-4 cm and with a normal contralateral kidney (4, 13). Such surgery is especially suitable for younger patients and patients with hereditary renal cell carcinoma having a high incidence of multifocal and bilateral tumors. Recent data indicate that nephron-sparing surgery and radical nephrectomy gives about equally effective curative treatment for elective patients. However, for patients with a normal functioning contralateral kidney, there is no clear evi-dence for a significant gain in renal function after nephron-sparing surgery compared with radical nephrectomy which would solely justify the routine use of nephron-sparing surgery. Nephron-sparing surgery is necessary in patients with imperative indications and can be recommended for patients with elective indications in centres with necessary experience of such surgery. The definitive role of nephronsparing surgery in the therapy of RCC, compared with radical nephrectomy, should be further evaluated in prospective, randomized studies comparing morbidity, long-term renal function, and survival. 
